MedTrace Logo

Transcranial Magnetic Stimulation Treatment of Hoarding Disorder

NCT02236767 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2016-10-06

Study results available
· View outcomes & findings →

Summary

This is multiple baseline study including up to three participants with a primary diagnosis of hoarding disorder. All patients will receive unblinded repetitive transcranial magnetic stimulation study intervention.

Conditions

  • Hoarding

Interventions

DEVICE

Neurostar Transcranial Magnetic Stimulation Therapy System

Treatment will entail daily (5 days/week) sessions of repetitive transcranial magnetic stimulation for 6 weeks employing right-sided, low frequency stimulation (1 Hz, 900 pulses/session for 30 sessions, 27,000 total pulses, intensity at 90% of the passive motor threshold) to the dorsolateral prefrontal cortex (DLPFC).

Sponsors & Collaborators

  • Neuronetics

    collaborator OTHER

  • Hartford Hospital

    lead OTHER

Principal Investigators

  • Gretchen J Diefenbach, Ph.D. · Hartford Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02236767 on ClinicalTrials.gov